| |
| |
|
| Insider
Information: |
Beeler Brian K |
| Relationship: |
EVP, General Counsel |
| City: |
Dublin |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
62,775 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,776,533 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,775 |
|
|
| Total
Value |
$1,776,533 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
EVP, General Counsel |
2021-09-17 |
62,775 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
EVP, General CounselOfficer |
• – – |
2015-05-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,243 |
|
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General CounselOfficer |
• – – |
2015-05-06 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
19,377 |
|
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-04-07 |
4 |
AS |
$32.50 |
$9,653 |
D/D |
(297) |
110,086 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-02-17 |
4 |
D |
$87.17 |
$60,670 |
D/D |
(696) |
122,521 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2018-01-02 |
4 |
D |
$15.02 |
$18,084 |
D/D |
(1,204) |
55,808 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,571 |
123,217 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-01-21 |
4/A |
D |
$38.25 |
$69,806 |
D/D |
(1,825) |
107,055 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-01-21 |
4 |
D |
$77.43 |
$141,387 |
D/D |
(1,826) |
121,646 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-04-06 |
4 |
AS |
$32.50 |
$77,025 |
D/D |
(2,370) |
110,383 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-06-01 |
4 |
AS |
$50.23 |
$119,045 |
D/D |
(2,370) |
35,885 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-07-28 |
4 |
D |
$102.50 |
$263,733 |
D/D |
(2,573) |
99,959 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2018-03-23 |
4 |
D |
$13.86 |
$38,586 |
D/D |
(2,784) |
62,524 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2016-03-23 |
4 |
D |
$16.32 |
$48,226 |
D/D |
(2,955) |
37,081 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2017-03-23 |
4 |
D |
$14.56 |
$43,025 |
D/D |
(2,955) |
52,383 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2018-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,200 |
57,012 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2016-01-02 |
4 |
D |
$21.67 |
$81,067 |
D/D |
(3,741) |
26,402 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2017-01-02 |
4 |
D |
$16.18 |
$62,633 |
D/D |
(3,871) |
45,838 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-01-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
4,119 |
108,880 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,120 |
123,472 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2019-03-23 |
4 |
D |
$26.84 |
$112,970 |
D/D |
(4,209) |
104,707 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2020-02-19 |
4 |
D |
$36.06 |
$163,496 |
D/D |
(4,534) |
112,753 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,806 |
102,532 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2019-12-18 |
4 |
AS |
$35.00 |
$235,060 |
D/D |
(6,716) |
77,917 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2019-01-05 |
4 |
D |
$20.39 |
$162,345 |
D/D |
(7,962) |
88,827 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
EVP, General Counsel |
• – – |
2019-02-20 |
4 |
D |
$21.54 |
$181,475 |
D/D |
(8,425) |
99,416 |
0 |
- |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
